Type 2 Diabetes at a Military Health Centre in Brazil: Clinical and Pharmacotherapeutic Profile

IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM
André Henrique Freitas de Braga e Bessa, Julieta Ueta, V. D. Mayrink, R. Oliveira
{"title":"Type 2 Diabetes at a Military Health Centre in Brazil: Clinical and Pharmacotherapeutic Profile","authors":"André Henrique Freitas de Braga e Bessa, Julieta Ueta, V. D. Mayrink, R. Oliveira","doi":"10.5603/cd.98362","DOIUrl":null,"url":null,"abstract":"Objective: To analyze the clinical and pharmacothera-peutic profile of people with type 2 diabetes (T2D) at a military health center in Brazil. Materials and methods: This is a cross-sectional study. The sample of 170 medical records was selected by means of probabilistic sampling. The data collected were sociodemographic, clinical and laboratory data related to diabetes, as well as prescribed medications. Results: Most of the subjects were male (57.6%), elderly (64.7%) and inactive military (55.2%). Adequate gly - cemic control was observed in 75.9% of the subjects, which was positively associated with multimorbidity and mono-therapeutic treatment (p < 0.05). Negative associations were observed in those subjects attend - ing medical appointments less frequently and using prescribed insulin (p < 0.05). Medications prescribed for treatment of T2D were the following: metformin (90.6%), sulfonylureas (22.9%), dipeptidyl peptidase in - hibitors-4 (16.5%) and sodium-glucose 2 co-transporter inhibitors (10.0%), in which 50.6% were monotherapy. Multimorbidity was 97.6%, in which systemic arte - rial hypertension (71.8%), lipid disorders (65.9%) and cardiovascular diseases (26.5%) were the main clinical conditions.","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/cd.98362","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To analyze the clinical and pharmacothera-peutic profile of people with type 2 diabetes (T2D) at a military health center in Brazil. Materials and methods: This is a cross-sectional study. The sample of 170 medical records was selected by means of probabilistic sampling. The data collected were sociodemographic, clinical and laboratory data related to diabetes, as well as prescribed medications. Results: Most of the subjects were male (57.6%), elderly (64.7%) and inactive military (55.2%). Adequate gly - cemic control was observed in 75.9% of the subjects, which was positively associated with multimorbidity and mono-therapeutic treatment (p < 0.05). Negative associations were observed in those subjects attend - ing medical appointments less frequently and using prescribed insulin (p < 0.05). Medications prescribed for treatment of T2D were the following: metformin (90.6%), sulfonylureas (22.9%), dipeptidyl peptidase in - hibitors-4 (16.5%) and sodium-glucose 2 co-transporter inhibitors (10.0%), in which 50.6% were monotherapy. Multimorbidity was 97.6%, in which systemic arte - rial hypertension (71.8%), lipid disorders (65.9%) and cardiovascular diseases (26.5%) were the main clinical conditions.
巴西一家军事医疗中心的 2 型糖尿病患者:临床和药物治疗概况
目的分析巴西一家军事医疗中心的 2 型糖尿病(T2D)患者的临床和药物治疗情况。材料与方法这是一项横断面研究。研究采用概率抽样法,选取了 170 份病历样本。收集的数据包括与糖尿病相关的社会人口学、临床和实验室数据,以及处方药物。结果显示大部分受试者为男性(57.6%)、老年人(64.7%)和非现役军人(55.2%)。75.9%的受试者血糖控制良好,这与多病症和单一疗法呈正相关(p < 0.05)。就诊次数较少和使用处方胰岛素的受试者则呈负相关(p < 0.05)。治疗 T2D 的处方药物如下:二甲双胍(90.6%)、磺脲类药物(22.9%)、二肽基肽酶抑制剂-4(16.5%)和钠-葡萄糖 2 协同转运体抑制剂(10.0%),其中 50.6% 为单一疗法。多病率为 97.6%,其中系统性动脉高血压(71.8%)、血脂紊乱(65.9%)和心血管疾病(26.5%)是主要的临床症状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Diabetology
Clinical Diabetology ENDOCRINOLOGY & METABOLISM-
CiteScore
0.90
自引率
14.30%
发文量
49
审稿时长
25 weeks
期刊介绍: Clinical Diabetology hereinafter referred to as ‘CD’ or ′the Journal′, is a peer-reviewed, open access journal covering broad spectrum of topics in diabetology and aiming to advance the knowledge and science of this rapidly evolving field. The Journal is the official bimonthly of the Diabetes Poland (Polish Diabetes Association) and publishes review articles, original clinical and experimental investigations in the field of diabetology, case reports, letters and editorial comments . The Journal has been published in full text English since 2016.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信